Eventually, acquisition of somatic mutations, mainly in STAT3 and other genes of the JAK/STAT pathway [54,62], may initiate and promote the monoclonal expansion observed in LGLL and explain, from this point forward, the divergent but parallel progression of LGLL and RA within a patient (Figure 1). This evidence concerns the gene SOAT1 and T-cell large granular lymphocyte leukemia.